Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cooper

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Plos One|February 11, 2020
Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineeringShan Zong, Tiejuan Mi, Leo G Flores, et al.
JAMA|January 27, 1989
Detection and surveillance of colorectal cancerD E Fleischer, S B Goldberg, T H Browning, et al.
Bioinformatics (Oxford, England)|June 11, 2015
Automated profiling of individual cell-cell interactions from high-throughput time-lapse imaging microscopy in nanowell grids (TIMING)Amine Merouane, Nicolas Rey-Villamizar, Yanbin Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2008
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancerBrian A Rabinovich, Yang Ye, Tamara Etto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapyMinying Zhang, Sourindra Maiti, Chantale Bernatchez, et al.
Cancer Gene Therapy|May 15, 2018
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System<sup>®</sup> (RTS<sup>®</sup>) gene switch as gene therapy for the treatment of gliomaJohn A Barrett, Hongliang Cai, John Miao, et al.
Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.
Human Gene Therapy|April 12, 2018
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic LeukemiaChiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, et al.
Cancer Research|May 3, 2011
Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010Hildegund C J Ertl, John Zaia, Steven A Rosenberg, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Plos One|February 11, 2020
Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineeringShan Zong, Tiejuan Mi, Leo G Flores, et al.
JAMA|January 27, 1989
Detection and surveillance of colorectal cancerD E Fleischer, S B Goldberg, T H Browning, et al.
Bioinformatics (Oxford, England)|June 11, 2015
Automated profiling of individual cell-cell interactions from high-throughput time-lapse imaging microscopy in nanowell grids (TIMING)Amine Merouane, Nicolas Rey-Villamizar, Yanbin Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2008
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancerBrian A Rabinovich, Yang Ye, Tamara Etto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapyMinying Zhang, Sourindra Maiti, Chantale Bernatchez, et al.
Cancer Gene Therapy|May 15, 2018
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System<sup>®</sup> (RTS<sup>®</sup>) gene switch as gene therapy for the treatment of gliomaJohn A Barrett, Hongliang Cai, John Miao, et al.
Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.
Human Gene Therapy|April 12, 2018
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic LeukemiaChiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, et al.
Cancer Research|May 3, 2011
Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010Hildegund C J Ertl, John Zaia, Steven A Rosenberg, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Pageof 16